# A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR

> **NCT00198159** · PHASE2 · TERMINATED · sponsor: **Indiana University** · enrollment: 21 (—)

## Conditions studied

- Refractory Germ Cell Tumors Expressing EGRF

## Interventions

- **DRUG:** ZD1839 Iressa

## Key facts

- **NCT ID:** NCT00198159
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09
- **Primary completion:** 2006-02
- **Final completion:** 2006-03
- **Target enrollment:** 21 (—)
- **Last updated:** 2014-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198159, "A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00198159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*